Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Farmers Insurance
Healthtrust
Dow
Harvard Business School
US Army
Accenture
Cerilliant
Citi
Moodys

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,781,571

« Back to Dashboard

Which drugs does patent 8,781,571 protect, and when does it expire?


Patent 8,781,571 protects IONSYS and is included in one NDA.

This patent has seventy-one patent family members in eighteen countries.

Summary for Patent: 8,781,571

Title:Switch validation circuit and method
Abstract: A switch operated therapeutic agent delivery device is described. Embodiments of the operated therapeutic agent delivery device include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, and a switch integrity subcircuit which is used to detect a fault or a precursor to a fault.
Inventor(s): Lemke; John (Pleasanton, CA), Satre; Scot (Brentwood, CA), Chen; Corinna X. (Oakland, CA), Read; Brian W. (Brier, WA)
Assignee: Incline Therapeutics, Inc. (Redwood City, CA)
Application Number:13/249,975
Patent Claim Types:
see list of patent claims
Device; Delivery; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
The Medicines Co
IONSYS
fentanyl hydrochloride
SYSTEM;IONTOPHORESIS, TRANSDERMAL021338-001May 22, 2006RXYesYes► Subscribe► SubscribeY METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,781,571

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,364,656Method of storing an electrotransport drug delivery device► Subscribe
8,301,238Two-part electrotransport device► Subscribe
8,428,709Current control for electrotransport drug delivery► Subscribe
9,095,706Self-test for analgesic product► Subscribe
9,645,179Self-test for analgesic product► Subscribe
8,428,708Self-test for analgesic product► Subscribe
9,731,121Switch validation circuit and method► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,781,571

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2012238095► Subscribe
Australia2012238096► Subscribe
Australia2013266914► Subscribe
Australia2013274873► Subscribe
Australia2015271708► Subscribe
Brazil112013024783► Subscribe
Brazil112013025000► Subscribe
Canada2828613► Subscribe
Canada2828617► Subscribe
Canada2873425► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Baxter
Accenture
Cerilliant
Express Scripts
Johnson and Johnson
Daiichi Sankyo
Farmers Insurance
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot